The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: Implication of polyadenylation in a cell type specific manner

Cancer Chemotherapy and Pharmacology

Volumn 61, Issue 2, 2008, Pages 251-265

  Thomadaki, Hellinida ^a,b   Scorilas, Andreas ^b   Tsiapalis, Chris Milto ^c   Havredaki, Maria ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Anticancer drugs; Cancer; Cordycepin; Etoposide; Leukemia; PAP

Indexed keywords

3 (5 DIMETHYLTHIAZOL 2 YL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BROMINE DERIVATIVE; CASPASE 6; CORDYCEPIN; ETOPOSIDE; POLYNUCLEOTIDE ADENYLYLTRANSFERASE; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; APOPTOSIS; ARTICLE; CANCER THERAPY; CELL CYCLE; CELL TYPE; CONTROLLED STUDY; CYTOTOXICITY; DNA CLEAVAGE; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOMA CELL; POLYADENYLATION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CASPASE 6; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DEOXYADENOSINES; DNA FRAGMENTATION; ETOPOSIDE; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INDOLES; LEUKEMIA; MEMBRANE POTENTIALS; MITOCHONDRIAL MEMBRANES; NEOPLASMS; POLY A;

EID: 36348990161     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-007-0467-y     Document Type: Article

References (69)

1. Funk JO, Walczak H, Voigtlander C, Berchtold S, Baumeister T, Rauch P, Rossner S, Steinkasserer A, Schuler G, Lutz MB (2000) Cutting edge: resistance to apoptosis and continuous proliferation of dendritic cells deficient for TNF receptor-1. J Immunol 165:4792-4796
2. Foster JR (2000) Cell death and cell proliferation in the control of normal and neoplastic tissue growth. Toxicol Pathol 28:441-446
3. Solary E, Droin N, Bettaieb A, Corcos L, Dimanche-Boitrel MT, Garrido C (2000) Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies. Leukemia 14:1833-1849
4. Malaguarnera L (2004) Implications of apoptosis regulators in tumorigenesis. Cancer Metastasis Rev 23:367-387
5. Schulze-Bergkamen H, Krammer PH (2004) Apoptosis in cancer-implications for therapy. Semin Oncol 31:90-119
6. Blagosklonny MV (2004) Prospective strategies to enforce selectively cell death in cancer cells. Oncogene 23:2967-2975
7. Debatin KM, Krammer PH (2004) Death receptors in chemotherapy and cancer. Oncogene 23:2950-2966
8. Costantini P, Jacotot E, Decaudin D, Kroemer G (2000) Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst 92:1042-1053
9. Hu W, Kavanagh JJ (2003) Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 4:721-729
10. Cummings J, Smyth JF (1993) DNA topoisomerase I and II as targets for rational design of new anticancer drugs. Ann Oncol 4:533-543
11. Zhao J, Hyman L, Moore C (1999) Formation of mRNA 3′ ends in eukaryotes: mechanism, regulation and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 63:405-445
12. Wahle E, Ruegsegger U (1999) 3′-end processing of pre-mRNA in eukaryotes. FEMS Microbiol Rev 23:277-295
13. Raabe T, Bollum FJ, Manley JL (1991) Primary structure and expression of bovine poly(A) polymerase. Nature 353:229-234
14. Wahle E, Martin G, Schiltz E, Keller W (1991) Isolation and expression of cDNA clones encoding mammalian poly(A) polymerase. EMBO J 10:4251-4257
15. Zhao W, Manley JL (1996) Complex alternative RNA processing generates an unexpected diversity of poly(A) polymerase isoforms. Mol Cell Biol 16:2378-2386
16. Kashiwabara S, Zhuang T, Yamagata K, Noguchi J, Fukamizu A, Baba T (2000) Identification of a novel isoform of poly(A) polymerase, TPAP, specifically present in the cytoplasm of spermatogenic cells. Dev Biol 228:106-115
17. Topalian SL, Kaneko S, Gonzales MI, Bond GL, Ward Y, Manley JL (2001) Identification and functional characterization of neo-poly(A) polymerase, an RNA processing enzyme overexpressed in human tumors. Mol Cell Biol 21:5614-5623
18. Kyriakopoulou CB, Nordvarg H, Virtanen A (2001) A novel nuclear human poly(A) polymerase (PAP), PAP gamma. J Biol Chem 276:33504-33511
19. Scorilas A (2002) Polyadenylate polymerase (PAP) and 3′ end pre-mRNA processing: function, assays, and association with disease. Crit Rev Clin Lab Sci J39:193-224
20. Colgan DF, Murthy KG, Prives C, Manley JL (1996) Cell-cycle related regulation of poly(A) polymerase by phosphorylation. Nature 384:282-285
21. Colgan DF, Murthy KG, Zhao W, Prives C, Manley JL (1998) Inhibition of poly(A) polymerase requires p34cdc2/cyclin B phosphorylation of multiple consensus and non-consensus sites. EMBO J 17:1053-1062
22. Mouland AJ, Coady M, Yao XJ, Cohen EA (2002) Hypophosphorylation of poly(A) polymerase and increased polyadenylation activity are associated with human immunodeficiency virus type 1 Vpr expression. Virology 292:321-330
23. Zhao W, Manley JL (1998) Deregulation of poly(A) polymerase interferes with cell growth. Mol Cell Biol 18:5010-5020
24. Kazazoglou T, Tsiapalis CM, Havredaki M (1987) Polyadenylate polymerase activity in stationary and growing cell cultures. Exp Cell Biol 55:164-172
25. Ballantyne S, Bilger A, Astrom J, Virtanen A, Wickens M (1995) Poly(A) polymerases in the nucleus and cytoplasm of frog oocytes: dynamic changes during oocyte maturation and early development. RNA 1:64-78
26. Perez S, Trangas T, Kokkinopoulos D, Tsiapalis CM, Papamichail M (1987) Polyadenylic acid metabolizing enzyme levels during induction of differentiation in a human leukemia T-cell line with phorbol ester. J Natl Cancer Inst 78:407-411
27. Trangas T, Courtis N, Pangalis GA, Cosmides HV, Ioannides C, Papamichail M, Tsiapalis CM (1984) Polyadenylic acid polymerase activity in normal and leukemic human leukocytes. Cancer Res 44:3691-3697
28. Pangalis GA, Trangas T, Roussou PA, Tsiapalis CM (1985) Poly(A)-polymerase activity in chronic lymphocytic leukemia of the B cell type. Acta Haematol 74:31-34
29. Sasaki R, Minowada J, Bollum FJ, Miura Y (1990) Polyadenylic acid polymerase activity in chronic myelogenous leukemia. Leuk Res 14:273-278
30. Scorilas A, Courtis N, Yotis J, Talieri M, Michailakis M, Trangas T (1998) Poly(A) polymerase activity levels in breast tumour cytosols. J Exp Clin Cancer Res 17:511-518
31. Scorilas A, Talieri M, Ardavanis A, Courtis N, Yotis J, Dimitriadis E, Tsiapalis C, Trangas T (2000) Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: a new independent prognostic marker in primary breast cancer. Cancer Res 60:5427-5433
32. Bodeker H, Vasseur S, Dusetti NJ, Dagorn JC, Iovanna JL (1998) PAP gene transcription induced by cycloheximide in AR4-2J cells involves ADP-ribosylation. Biochem Biophys Res Commun 251:710-713
33. Atabasides H, Tsiapalis CM, Havredaki M (1998) Dephosphorylation, proteolysis and reduced activity of poly(A) polymerase associated with U937 cell apoptosis. Exp Cell Res 244:433-440
34. Balatsos NA, Havredaki M, Tsiapalis CM (2000a) Anticancer drug action on poly(A) polymerase activity and isoforms during HeLa and WISH cell apoptosis. Int J Biol Markers 15:171-178
35. Balatsos NA, Havredaki M, Tsiapalis CM (2000b) Early 5-fluorouracil- induced changes of poly(A) polymerase in HeLa and WISH cells. Int J Biol Markers 15:294-299
36. Balatsos NA, Lallas G, Havredaki M, Tsiapalis CM (2001) Drug action on poly(A) polymerase activity and isoforms during U937 cell apoptosis. J Exp Clin Cancer Res 20:63-69
37. Thomadaki E, Havredaki M, Tsiapalis CM (2004) PAP modulations in Daudi cells and Molt-3 cells treated with etoposide are mutually associated with morphological evidence of apoptosis. Int J Biol Markers 19:203-212
38. Thomadaki H, Tsiapalis CM, Scorilas A (2005) Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction. Biol Chem 386:471-480
39. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rosen A (1994) Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 269:30757-30760
40. Marissen WE, Triyoso D, Younan P, Lloyd RE (2004) Degradation of poly(A)-binding protein in apoptotic cells and linkage to translation regulation. Apoptosis 9:67-75
41. Saitoch S, Chabes A, McDonald WH, Thelander L, Yates JR, Russell P (2002) Cid13 is a cytoplasmic poly(A) polymerase that regulates ribonucleotide reductase mRNA. Cell 109:563-573
42. Kashiwabara S, Noguchi J, Zhuang T, Ohmura K, Honda A, Sugiura S, Miyamoto K, Takahashi S, Inoue K, Ogura A, Baba T (2002) Regulation of spermatogenesis by testis-specific, cytoplasmic poly(A) polymerase TPAP. Science 298:1999-2002
43. Zhuang T, Kashiwabara S, Noguchi J, Baba T (2004) Transgenic expression of testis-specific poly(A) polymerase TPAP in wild-type and TPAP-deficient mice. J Reprod Dev 50:207-213
44. Schiavone N, Rosini P, Quattrone A, Donnini M, Lapucci A, Citti L, Bevilacqua A, Nicolin A, Capaccioli S (2000) A conserved AU-rich element in the 3′ untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis. FASEB J 14:174-184
45. Kim H, You S, Foster LK, Farris J, Foster DN (2001) The rapid destabilization of p53 mRNA in immortal chicken embryo fibroblast cells. Oncogene 20:5118-5123
46. Barry MA, Behnke CA, Eastman A (1990) Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40:2353-2362
47. Lazebnik YA, Cole S, Cooke CA, Nelson WG, Earnshaw WC (1993) Nuclear events of apoptosis in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis. J Cell Biol 123:7-22
48. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
49. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
50. Burnette WN (1981) "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulphate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112:195-203
51. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
52. Bollum FJ, Chang LM, Tsiapalis CM, Dorson JW (1974) Nucleotide polymerizing enzymes from calf thymus gland. In: Colowick SP, Kaplan NO (eds) Methods Enzymol. Academic Press, New York, vol 29, p 70
53. Didelot C, Mirjolet JF, Barberi-Heyob M, Ramacci C, Merlin JL (2002) Radiation could induce p53-independent and cell cycle-unrelated apoptosis in 5-fluorouracil radiosensitized head and neck carcinoma cells. Can J Physiol Pharmacol 80:638-643
54. Chou RH, Huang H (2002) Restoration of p53 tumor suppressor pathway in human cervical carcinoma cells by sodium arsenite. Biochem Biophys Res Commun 293:298-306
55. Polla BS, Kantengwa S, Francois D, Salvioli S, Franceschi C, Marsac C, Cossarizza A (1996) Mitochondria are selective targets for the protective effects of heat shock against oxidative injury. Proc Natl Acad Sci USA 93:6458-6463
56. m changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411:77-82
57. Komatsu N, Oda T, Muramatsu T (1998) Involvement of both caspase-like proteases and serine proteases in apoptotic cell death induced by ricin, modeccin, diphtheria toxin and pseudomonas toxin. J Biochem 124:1038-1044
58. Koc Y, Urbano AG, Sweeney EB, McCaffrey R (1996) Induction of apoptosis by cordycepin in ADA-inhibited TdT-positive leukemia cells. Leukemia 10:1019-1024
59. Müller WE, Seibert G, Beyer R, Breter HJ, Maidhof A, Zahn RK (1977) Effect of cordycepin on nucleic acid metabolism in L5178Y cells and on nucleic acid-synthesizing enzyme systems. Cancer Res 37:3824-3833
60. +) leukemic cells. Biochem Pharmacol 59:273-281
61. Niitsu N, Umeda M, Honma Y (2000) Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs. Leuk Res 24:1-9
62. Niitsu N, Yamaguchi Y, Umeda M, Honma Y (1998) Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2′-deoxycoformycin and 2′-deoxyadenosine: association with dATP-dependent activation of caspase-3. Blood 92:3368-3375
63. Chen LS, Sheppard TL (2004) Chain termination and inhibition of Saccharomyces cerevisiae poly(A) polymerase by C-8-modified ATP analogs. J Biol Chem 279:40405-40411
64. Kuznetsov DA, Musajev NI (1990) The molecular mode of brain mRNA processing damage followed by the suppression of post-transciptional poly(A) synthesis with cordycepin. Int J Neurosci 51:53-67
65. Thomadaki H, Scorilas A (2006) BCL2 family of apoptosis-related genes: functions and clinical implications in cancer. Crit Rev Clin Lab Sci 43:1-67
66. Thomadaki H, Talieri M, Scorilas A (2006) Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer. Cancer Lett (Epub ahead of print)
67. Floros KV, Thomadaki H, Lallas G, Katsaros N, Talieri M, Scorilas A (2003) Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells: differential expression of BCL2 and novel apoptosis-related gene BCL2L12. Ann N Y Acad Sci 1010:153-158
68. Floros KV, Thomadaki H, Katsaros N, Talieri M, Scorilas A (2004) mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. Biol Chem 385:1099-1103
69. Thomadaki H, Talieri M, Scorilas A (2006) Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS. Biol Chem 387:1081-1086